Cardiol Therapeutics Inc - Ordinary Shares - Class A Stock News
$1.41
4.08%
yesterday
Nasdaq,
Jun 27, 10:00 pm CET
Cardiol Therapeutics Inc - Ordinary Shares - Class A Stock News
Positive
Proactive Investors
●
4 months ago
Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) said that new research published in the Journal of the American College of Cardiology: Basic to Translational Science (JACBTS) supports the potential of its cannabidiol-based drug candidate CRD-38 to treat heart failure. The study, conducted by scientists at Tecnológico de Monterrey in collaboration with researchers from the DeBakey Heart and Vascula...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
